Projects per year
Personal profile
Area of Expertise
Pre-Clinical Services evaluate new therapies against infections using animal models. These studies are done in collaboration with pharmaceutical and academic researchers, and several of these therapies are now being used clinically to treat patients.
Education/Academic qualification
MS in Biology, Fairleigh Dickinson University
BS in Microbiology, Rutgers University
Fingerprint
Dive into the research topics where William Weiss is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Task C08:Vaccine Testing in Aerosol Challenge Monkeypox NHP Model
Weiss, W., SAIA, T., VANCOTT, T., MIRSALIS, J., BRUCE, M., MEISTER, G., MENNE, S., BARRETT, A., BARRETT, A., BARRETT, A., PALESE, P., BULLER, M., LEWIS, M., KORBA, B., KORBA, B., PARISH, T., PARISH, T., RAYNER, J., RICHTER, S., Minyard, M. B., NOAH, J., NOAH, J., Ananthan, S., PRICHARD, M., PRICHARD, M., PRICHARD, M., PATTERSON, T., PATTERSON, T., PATTERSON, T., SHAW, E., SHAW, E., GRIFFISS, M., GRIFFISS, M. & HOOK III, E.
National Institute of Allergy and Infectious Diseases
Project: Research
-
FDA public workshop summary: Advancing animal models for antibacterial drug development
Byrne, J. M., Waack, U., Weinstein, E. A., Joshi, A., Shurland, S. M., Iarikov, D., Bulitta, J. B., Diep, B. A., Guina, T., Hope, W. W., Lawrenz, M. B., Lepak, A. J., Luna, B. M., Miesel, L., Phipps, A. J., Walsh, T. J., Weiss, W., Amini, T. & Farley, J. J., Jan 2021, In: Antimicrobial agents and chemotherapy. 65, 1, e01983-20.Research output: Contribution to journal › Review article › peer-review
2 Scopus citations -
C1-CBP-vancomycin: Impact of a Vancomycin C-Terminus Trimethylammonium Cation on Pharmacological Properties and Insights into Its Newly Introduced Mechanism of Action
Wu, Z. C., Isley, N. A., Okano, A., Weiss, W. J. & Boger, D. L., 7 Feb 2020, In: Journal of Organic Chemistry. 85, 3, p. 1365-1375 11 p.Research output: Contribution to journal › Article › peer-review
7 Scopus citations -
DAV131A Protects Hamsters from Lethal Clostridioides difficile Infection Induced by Fluoroquinolones
Saint-Lu, N., Burdet, C., Sablier-Gallis, F., Corbel, T., Nevière, A., Sayah-Jeanne, S., Pulse, M., Weiss, W., Ferreira, S., Andremont, A., Mentré, F. & de Gunzburg, J., 2020, In: Antimicrobial agents and chemotherapy. 64, 1, e01196-19.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- And Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections
Liu, B., Trout, R. E. L., Chu, G. H., Mcgarry, D., Jackson, R. W., Hamrick, J. C., Daigle, D. M., Cusick, S. M., Pozzi, C., De Luca, F., Benvenuti, M., Mangani, S., Docquier, J. D., Weiss, W. J., Pevear, D. C., Xerri, L. & Burns, C. J., 26 Mar 2020, In: Journal of Medicinal Chemistry. 63, 6, p. 2789-2801 13 p.Research output: Contribution to journal › Article › peer-review
Open Access56 Scopus citations -
In Vivo Efficacy of Novel Monobactam LYS228 in Murine Models of Carbapenemase-Producing Klebsiella pneumoniae Infection
Weiss, W. J., Pulse, M. E., Nguyen, P. & Growcott, E. J., Apr 2019, In: Antimicrobial agents and chemotherapy. 63, 4, e02214-18.Research output: Contribution to journal › Article › peer-review
5 Scopus citations